Sihuan Pharmaceutical Holdings Group Ltd. Stock Shanghai - Hong Kong Stock Connect
Equities
460
BMG8162K1137
Pharmaceuticals
Sales 2024 * | 2.73B 378M 2.95B 515M | Sales 2025 * | 3.19B 441M 3.44B 600M | Capitalization | 5.24B 726M 5.66B 988M |
---|---|---|---|---|---|
Net income 2024 * | 107M 14.81M 116M 20.17M | Net income 2025 * | 337M 46.66M 364M 63.51M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 1.65 x |
P/E ratio 2024 * |
56.5
x | P/E ratio 2025 * |
14.1
x | Employees | - |
Yield 2024 * |
8.85% | Yield 2025 * |
8.85% | Free-Float | 44.97% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Cheng Guo
FOU | Founder | 60 | 00-12-31 |
Gui Li Miao
DFI | Director of Finance/CFO | 50 | - |
Zhong Xin Jia
COO | Chief Operating Officer | 65 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Sheng Che
FOU | Founder | 63 | 00-12-31 |
Wei Cheng Guo
FOU | Founder | 60 | 00-12-31 |
Jiong Long Zhang
CIO | Chief Investment Officer | 62 | 06-05-17 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |